Gladstone Institutional Advisory LLC Seagen Inc. Transaction History

Gladstone Institutional Advisory LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $3,255 - $3,674	17 Added 0.54%	3,163 $671,000
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $590,315 - $648,862	3,146 New	3,146 $605,000
Q3 2022 Jan 27, 2023	BUY	$135.27 - $180.11 $182,614 - $243,148	1,350 Added 40.11%	4,716 $645,000
Q3 2022 Oct 20, 2022	BUY	$135.27 - $180.11 $182,614 - $243,148	1,350 Added 40.11%	4,716 $645,000
Q2 2022 Jan 27, 2023	SELL	$108.81 - $179.33 $146,893 - $242,095	-1,350 Reduced 28.63%	3,366 $596,000
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $366,254 - $603,624	3,366 New	3,366 $596,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.